Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection

Background. A prospective study was initiated to explore an approach of limited therapy in elderly patients with early clinical stage breast cancer.

[1]  C. Redmond,et al.  A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.

[2]  A. Luini,et al.  Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. , 1993, The New England journal of medicine.

[3]  R. Arriagada,et al.  Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy. , 1987, International journal of radiation oncology, biology, physics.

[4]  L. Fallowfield,et al.  Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone , 1991, The British journal of surgery.

[5]  S. Moolgavkar,et al.  Effect of age on incidence of breast cancer in females. , 1979, Journal of the National Cancer Institute.

[6]  C. Perez,et al.  Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. , 1993, International journal of radiation oncology, biology, physics.

[7]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[8]  Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study. , 1982, British medical journal.

[9]  B. Asselain,et al.  Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer , 1992, The Lancet.

[10]  N. Robert,et al.  Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[12]  H Volk,et al.  Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Rubin,et al.  Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy. , 1988, International journal of radiation oncology, biology, physics.

[14]  N. Robert,et al.  Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. , 1989, International journal of radiation oncology, biology, physics.

[15]  F. Vicini,et al.  Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[17]  I. Ellis,et al.  Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. , 1992, European journal of cancer.

[18]  A. D. Schryver,et al.  Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .